Symposia: Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Hodgkin lymphoma, Biological therapies, Antibody Therapy, adult, epidemiology, Lymphomas, Non-Biological therapies, Clinical Research, genomics, Chemotherapy, Combination therapy, Diseases, patient-reported outcomes, Therapies, Immunotherapy, therapy sequence, real-world evidence, Adverse Events, Lymphoid Malignancies, young adult , Biological Processes, Monoclonal Antibody Therapy, Study Population, Human
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Hodgkin lymphoma, Biological therapies, Antibody Therapy, adult, epidemiology, Lymphomas, Non-Biological therapies, Clinical Research, genomics, Chemotherapy, Combination therapy, Diseases, patient-reported outcomes, Therapies, Immunotherapy, therapy sequence, real-world evidence, Adverse Events, Lymphoid Malignancies, young adult , Biological Processes, Monoclonal Antibody Therapy, Study Population, Human
Monday, December 12, 2022: 10:30 AM-12:00 PM
265-268
(Ernest N. Morial Convention Center)
Moderators:
Robin Gasiorowski, MA, FRACP, FRCPA, MBBS, Concord Hospital, University of Sydney
and
Ramon Garcia-Sanz, University Hospital of Salamanca
Disclosures:
Gasiorowski: MSD: Honoraria; Otsuka: Honoraria; Novartis: Honoraria; Astellas: Honoraria; Janssen: Honoraria; AbbVie: Honoraria; Antengene: Honoraria.
10:30 AM
10:45 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH